Skip to main content
. 2015 Dec 2;6(40):42557–42568. doi: 10.18632/oncotarget.6449

Figure 2. ROC curves showing the ability of the plasma concentrations of the 9 individual miRNAs (A-I) and the 9-miRNA panel (J) to differentiate the RA cases (n = 75) from the controls (n = 70).

Figure 2